BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 29551286)

  • 1. Up-regulation of microRNA-93 inhibits TGF-β1-induced EMT and renal fibrogenesis by down-regulation of Orai1.
    Ma J; Zhang L; Hao J; Li N; Tang J; Hao L
    J Pharmacol Sci; 2018 Apr; 136(4):218-227. PubMed ID: 29551286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of miR-23a inhibits high glucose-induced EMT and renal fibrogenesis by up-regulation of SnoN.
    Xu H; Sun F; Li X; Sun L
    Hum Cell; 2018 Jan; 31(1):22-32. PubMed ID: 28707079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
    Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Let-7d miRNA prevents TGF-β1-induced EMT and renal fibrogenesis through regulation of HMGA2 expression.
    Wang Y; Le Y; Xue JY; Zheng ZJ; Xue YM
    Biochem Biophys Res Commun; 2016 Oct; 479(4):676-682. PubMed ID: 27693697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice.
    Zhao Y; Yin Z; Li H; Fan J; Yang S; Chen C; Wang DW
    Aging Cell; 2017 Apr; 16(2):387-400. PubMed ID: 28127848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy.
    Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
    Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
    Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
    Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentially expressed microRNAs in bone marrow mesenchymal stem cell-derived microvesicles in young and older rats and their effect on tumor growth factor-β1-mediated epithelial-mesenchymal transition in HK2 cells.
    Wang Y; Fu B; Sun X; Li D; Huang Q; Zhao W; Chen X
    Stem Cell Res Ther; 2015 Sep; 6():185. PubMed ID: 26415502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-448-5p inhibits TGF-β1-induced epithelial-mesenchymal transition and pulmonary fibrosis by targeting Six1 in asthma.
    Yang ZC; Qu ZH; Yi MJ; Shan YC; Ran N; Xu L; Liu XJ
    J Cell Physiol; 2019 Jun; 234(6):8804-8814. PubMed ID: 30362537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy.
    Gao BH; Wu H; Wang X; Ji LL; Chen C
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1338-1349. PubMed ID: 32096183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-200a Inhibits Transforming Growth Factor β1-Induced Proximal Tubular Epithelial-Mesenchymal Transition by Targeting β-Catenin.
    Gong Y; Qin Z; Zhou B; Chen H; Shi Z; Zhang J
    Nephron; 2017; 137(3):237-249. PubMed ID: 28817830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells.
    Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM
    Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression.
    Wang Y; Liu L; Peng W; Liu H; Liang L; Zhang X; Mao Y; Zhou X; Shi M; Xiao Y; Zhang F; Zhang Y; Liu L; Yan R; Guo B
    J Cell Physiol; 2019 Aug; 234(10):17925-17936. PubMed ID: 30847937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-328 prevents renal fibrogenesis by directly targeting TGF-β2.
    He W; Zhuang J; Zhao ZG; Luo H; Zhang J
    Bratisl Lek Listy; 2018; 119(7):434-440. PubMed ID: 30160133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-92d-3p suppresses the progression of diabetic nephropathy renal fibrosis by inhibiting the C3/HMGB1/TGF-β1 pathway.
    Zhang Y
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 33729484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression.
    Wang B; Koh P; Winbanks C; Coughlan MT; McClelland A; Watson A; Jandeleit-Dahm K; Burns WC; Thomas MC; Cooper ME; Kantharidis P
    Diabetes; 2011 Jan; 60(1):280-7. PubMed ID: 20952520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
    Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
    Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy.
    Liu H; Wang X; Liu S; Li H; Yuan X; Feng B; Bai H; Zhao B; Chu Y; Li H
    Int J Biochem Cell Biol; 2016 Jan; 70():149-60. PubMed ID: 26646104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy.
    Wu J; Liu J; Ding Y; Zhu M; Lu K; Zhou J; Xie X; Xu Y; Shen X; Chen Y; Shao X; Zhu C
    Biochem Biophys Res Commun; 2018 Sep; 503(2):977-983. PubMed ID: 29932921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-130b increases fibrosis of HMC cells by regulating the TGF-β1 pathway in diabetic nephropathy.
    Ma Y; Shi J; Wang F; Li S; Wang J; Zhu C; Li L; Lu H; Li C; Yan J; Zhang X; Jiang H
    J Cell Biochem; 2019 Mar; 120(3):4044-4056. PubMed ID: 30260005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.